Parkside Financial Bank & Trust’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-470
| Closed | -$3.46K | – | 2061 |
|
|
2023
Q2 | $3.46K | Buy |
+470
| New | +$3.46K | ﹤0.01% | 1500 |
|
|
2022
Q4 | – | Sell |
-214
| Closed | -$4K | – | 2019 |
|
|
2022
Q3 | $4K | Buy |
214
+86
| +67% | +$1.61K | ﹤0.01% | 1289 |
|
|
2022
Q2 | $4K | Sell |
128
-31
| -19% | -$969 | ﹤0.01% | 1315 |
|
|
2022
Q1 | $7K | Sell |
159
-38
| -19% | -$1.67K | ﹤0.01% | 1148 |
|
|
2021
Q4 | $9K | Buy |
+197
| New | +$9K | ﹤0.01% | 1057 |
|
|
2020
Q3 | – | Sell |
-76
| Closed | -$6K | – | 1546 |
|
|
2020
Q2 | $6K | Sell |
76
-3
| -4% | -$237 | ﹤0.01% | 889 |
|
|
2020
Q1 | $5K | Buy |
79
+18
| +30% | +$1.14K | ﹤0.01% | 870 |
|
|
2019
Q4 | $3K | Hold |
61
| – | – | ﹤0.01% | 1044 |
|
|
2019
Q3 | $3K | Buy |
61
+11
| +22% | +$541 | ﹤0.01% | 1049 |
|
|
2019
Q2 | $2K | Buy |
50
+24
| +92% | +$960 | ﹤0.01% | 1157 |
|
|
2019
Q1 | $1K | Sell |
26
-5
| -16% | -$192 | ﹤0.01% | 1313 |
|
|
2018
Q4 | $1K | Buy |
31
+8
| +35% | +$258 | ﹤0.01% | 1194 |
|
|
2018
Q3 | $2K | Hold |
23
| – | – | ﹤0.01% | 1069 |
|
|
2018
Q2 | $1K | Hold |
23
| – | – | ﹤0.01% | 1217 |
|
|
2018
Q1 | $1K | Hold |
23
| – | – | ﹤0.01% | 1162 |
|
|
2017
Q4 | $1K | Hold |
23
| – | – | ﹤0.01% | 1111 |
|
|
2017
Q3 | $1K | Hold |
23
| – | – | ﹤0.01% | 1109 |
|
|
2017
Q2 | $1K | Hold |
23
| – | – | ﹤0.01% | 1114 |
|
|
2017
Q1 | $1K | Buy |
23
+2
| +10% | +$87 | ﹤0.01% | 1090 |
|
|
2016
Q4 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 1078 |
|